Swiss Pharmaceuticals & Biotech Top Dividend Payers

Novartis

Market Cap: CHF 247.3b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Tecan Group

Market Cap: CHF 1.7b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Roche Holding

Market Cap: CHF 298.4b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.